Clinical trial
A Prospective Observational Study to Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)
NCT04848779 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Observational Study to Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)
- Lead sponsor
- Sanofi
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- June 10, 2021
- Completion date
- October 28, 2026
- Enrollment
- 16 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.